7/11/2017
Fact-checking pharma: 5 cancer drug myths, busted
1/26/2017
Approval of ‘breakthrough’ hepatitis C drugs isn’t even half the story; now come the harms
1/9/2017
Whitewashing a black box warning: The Chantix story that didn’t get told
12/6/2016
With media watchdogs on the sidelines, pharma-funded advocacy groups pushed Cures Act to the finish line
11/29/2016
Off-label drug marketing: Who will decide what’s “truthful” when the evidence can’t be trusted?
10/31/2016
Early report card on quality of FDA news releases: C at best
10/25/2016
Black box warnings for ‘lifesaving’ hepatitis C drugs highlight systematic misinformation
9/28/2016
What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups
6/22/2016
What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug
6/13/2016
21st Century Cures Act nears passage with little news media scrutiny
